Skip to NavigationSkip to content

Top Ten most popular articles on this week!

Published on 12/07/19 at 08:53am

This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the United States pays the lowest drug prices in the world. The claim comes amid lively debate around drug pricing in the United States.

Across the pond, the UK Government said it would give boys the HPV vaccine in an effort to tackle cancers. The NHS also said it would try out a subscription style payment model for antibiotics in seeking to tackle the global crisis of antimicrobial resistance (AMR).

In other news GSK hired computation drug design expert Dr Kim Branson to head machine learning and AI as they opened new high tech facilities in Singapore. Meanwhile ViiV’s two ddrug HIV therapy beat out Gilead’s three drug treatment in a Phase 3 trial. For all this and more, check out this week’s top 10 stories on!

10. Boys in UK to be given HPV vaccine

Boys in the United Kingdom will from September be given the human papilloma virus (HPV) vaccine, the government has said. 

9.NHS to try out new subscription style payment model to pay for antibiotics

The NHS has said it will test the world’s first subscription style payment model to pay for antibiotics.

8. Pierre Fabre's triplet therapy makes strong showing in BRAF V600E-mutant metastatic colorectal cancer

Pierre Fabre has unveiled new Phase 3 data on its encorafenib triplet therapy in the treatment of BRAF V600E-mutant metastatic colorectal cancer (mCRC), in patients who have already received one or two lines of therapy. 

7. Novartis aims to solve EpiPen shortage with generic launch of Symjepi to US pharmacies

Novartis has announced the immediate availability of its generic epinephrine auto-injector in pharmacies throughout the US, as it moves to remedy the nation’s shortage of the potentially life-saving drug.

6. GSK hires computational drug design expert Dr Kim Branson as new head of machine learning and AI

British multinational GlaxoSmithKline have hired computational drug design expert Dr Kim Branson as the company’s new Senior Vice President, Global Head of Artificial Intelligence and Machine Learning.

5. GSK opens new manufacturing plants in Singapore

British multinational GlaxoSmithKline has opened two new manufacturing plants in Singapore.

4. NICE recommends Alnylam's Onpattro for inherited hATTR amyloidosis

NICE has passed positive recommendation for Alnylam’s Onpattro (patisiran) for the treatment of inherited hATTR amyloidosis, a progressive disease related to the production of the abnormal protein transtyretin which can lead to nerve and organ damage and even death.

3. ViiV Healthcare's two drug HIV therapy beats Gilead's three drug treatment in Phase 3 trial

Pfizer and GlaxoSmithKline’s HIV company, ViiV Healthcare, has said its two-drug combo Dovato (dolutegravir and lamuvidine) met its primary endpoint of maintaining viral suppression for at least six months in patients who had switched from a three drug cocktail made by Gilead.

2. NICE recommends Pfizer's Vizimpro, rejects AstraZeneca's Tagrisso, in non-small cell lung cancer

NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a U-turn on its previous decision to reject the drug for being an ineffective use of NHS resources.

1. Trump says executive order will ensure US will pay lowest prices in the world for drugs

President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United States pays the same price for pharmaceutical drugs as those countries that pay the lowest prices in the world. 


Good post but I was wondering if you could write a litte more on this subject? I’d be very thankful if you could elaborate a little bit further. Appreciate it! 電子煙誰在使用呢

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches